Evaluation of gastrointestinal symptoms in pediatric patients post hematopoietic stem cell transplantation: Ileo-colonoscopy versus sigmoidoscopy. A single-center experience and review of literature.
gastro-intestinal symptoms
graft-versus-host disease
hematopoietic stem cell transplantation
ileo-colonoscopy
sigmoidoscopy
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
revised:
28
06
2021
received:
05
02
2021
accepted:
29
06
2021
pubmed:
16
7
2021
medline:
19
3
2022
entrez:
15
7
2021
Statut:
ppublish
Résumé
Hematopoietic stem cell transplantation (HSCT) is a curative therapy used to treat high-risk hematological malignant disorders and other life-threatening nonmalignant diseases. Gastrointestinal (GI) symptoms post-HSCT might be due to GI graft-versus-host disease (GVHD) or GI infections or both. GI endoscopy with biopsies is safe and beneficial in guiding the management of GI symptoms in children after HSCT, justifying the therapeutic management and contributing to improved outcomes. A retrospective cohort study including 16 children with malignant and nonmalignant diseases that underwent allogeneic HSCT who had 24 ileo-colonoscopies performed for GI symptoms. To facilitate an evidence-based approach to the endoscopic evaluation of GI symptoms in pediatric patients post HSCT, we examined whether a full ileo-colonoscopy, which includes right colon and terminal ileum (TI), as opposed to a limited sigmoidoscopy, was more accurate in the evaluation of GI symptoms in pediatric patients post HSCT. Specific findings on the right colon/TI were found in nine out of 24 ileo-colonoscopies (38%, CI = 19%-59%). The macroscopic findings on ileo-colonoscopy were compared with the histopathologic findings. When macroscopic findings were present, there were matching histopathologic findings in 100% of cases. However, even in the absence of any macroscopic findings on ileo-colonoscopy, there were histopathological findings in 29% of the cases (p-value = .016). This cohort favors ileo-colonoscopy over sigmoidoscopy, with systematic biopsy sampling, in evaluating GI symptoms in pediatric patients post HSCT.
Sections du résumé
BACKGROUND
Hematopoietic stem cell transplantation (HSCT) is a curative therapy used to treat high-risk hematological malignant disorders and other life-threatening nonmalignant diseases. Gastrointestinal (GI) symptoms post-HSCT might be due to GI graft-versus-host disease (GVHD) or GI infections or both. GI endoscopy with biopsies is safe and beneficial in guiding the management of GI symptoms in children after HSCT, justifying the therapeutic management and contributing to improved outcomes.
METHODS
A retrospective cohort study including 16 children with malignant and nonmalignant diseases that underwent allogeneic HSCT who had 24 ileo-colonoscopies performed for GI symptoms. To facilitate an evidence-based approach to the endoscopic evaluation of GI symptoms in pediatric patients post HSCT, we examined whether a full ileo-colonoscopy, which includes right colon and terminal ileum (TI), as opposed to a limited sigmoidoscopy, was more accurate in the evaluation of GI symptoms in pediatric patients post HSCT.
RESULTS
Specific findings on the right colon/TI were found in nine out of 24 ileo-colonoscopies (38%, CI = 19%-59%). The macroscopic findings on ileo-colonoscopy were compared with the histopathologic findings. When macroscopic findings were present, there were matching histopathologic findings in 100% of cases. However, even in the absence of any macroscopic findings on ileo-colonoscopy, there were histopathological findings in 29% of the cases (p-value = .016).
CONCLUSIONS
This cohort favors ileo-colonoscopy over sigmoidoscopy, with systematic biopsy sampling, in evaluating GI symptoms in pediatric patients post HSCT.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e29235Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373(9674):1550-1561.
Svenberg P, Remberger M, Uzunel M, et al. Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation - a comparison of the last two decades. Pediatr Transplant. 2016;20(5):667-674.
Kambham N, Higgins JP, Sundram U, Troxell ML. Hematopoietic stem cell transplantation: graft versus host disease and pathology of gastrointestinal tract, liver, and lung. Adv Anat Pathol. 2014;21(5):301-320.
Gassas A, Krueger J, Schechter T, Zaidman I, Asim M, Ali M. Safety and role of gastrointestinal endoscopy in the management of gastrointestinal acute GVHD in children after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol. 2016;38(6):453-456.
Khan K, Schwarzenberg SJ, Sharp H, et al. Diagnostic endoscopy in children after hematopoietic stem cell transplantation. Gastrointest Endosc. 2006;64(3):379-385.
Lee KJ, Choi SJ, Yang HR, et al. Stepwise endoscopy based on sigmoidoscopy in evaluating pediatric graft-versus-host disease. Pediatr Gastroenterol Hepatol Nutr. 2016;19(1):29-37.
Nydegger A, Catto-Smith AG, Tiedemann K, Hardikar W. Diagnosis of gastrointestinal graft-versus-host disease - is rectal biopsy enough? Pediatr Blood Cancer. 2007;48(5):561-566.
Hiejima E, Nakase H, Matsuura M, et al. Diagnostic accuracy of endoscopic features of pediatric acute gastrointestinal graft-versus-host disease. Dig Endosc. 2016;28(5):548-555.
Kreisel W, Dahlberg M, Bertz H, et al. Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients. Bone Marrow Transplant. 2012;47(3):430-438.
Mårtensson T, Szakos A, Mellgren K, et al. Choice of endoscopic procedure in children with clinically suspected gastrointestinal graft-versus-host disease. J Pediatr Gastroenterol Nutr. 2018;66(5):744-750.
Shulman HM, Cardona DM, Greenson JK, Hingorani S. Histopathologic diagnosis of chronic graft versus host disease. Biol Blood Marrow Transpl. 2016;21(4):589-603.
Sugihara Y, Hiraoka S, Fujii N, et al. Villous atrophy in the terminal ileum is a specific endoscopic finding correlated with histological evidence and poor prognosis in acute graft-versus-host disease after allo-hematopoietic stem cell transplantation. BMC Gastroenterol. 2018;18(1):111.
Naymagon S, Naymagon L, Wong SY, et al. Acute graft-versus-host disease of the gut: considerations for the gastroenterologist. Nat Rev Gastroenterol Hepatol. 2017;14(12):711-726.
Thompson B, Salzman D, Steinhauer J, Lazenby AJ, Wilcox CM. Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: determination of the best diagnostic approach. Bone Marrow Transplant. 2006;38(5):371-376.
ASGE Standards of Practice Committee, Early DS, Lightdale JR, et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2018;87(2):327-337.
Ohwada S, Iida T, Hirayama D, et al. Clinicopathological comparison between acute gastrointestinal graft-versus-host disease and infectious colitis in patients after hematopoietic stem cell transplantation. PLoS One. 2018;13(7):e0200627.